bluebird bio, Inc. 3 SEC Filings

Filed On	Filing
24 Jun 2024	Form 3: Cloonan Michael, Director No securities owned
13 Jun 2024	Form 3: Sterling O. James, Chief Financial Officer No securities owned
05 Apr 2023	Form 3: Paulson Richard A., Director No securities owned
09 Jan 2023	Form 3: Vittiglio Joseph, Chief Business & Legal Officer No securities owned
07 Nov 2022	Form 3: Krawtschuk Christopher, Chief Financial Officer No securities owned
25 Aug 2022	Form 3: Colvin Richard A, Chief Medical Officer Holds 693 shares of Common Stock
09 Mar 2022	Form 3: Jones-Burton Charlotte, Director Holds 0 shares of No Securities are beneficially owned
13 Jan 2022	Form 3: Eggimann Anne-Virginie, Chief Regulatory Officer Holds 538 shares of Common Stock
08 Nov 2021	Form 3: Whitten Jessica, Chief Accounting Officer Holds 899 shares of Common Stock
08 Nov 2021	Form 3: Consylman Gina, Chief Financial Officer No securities owned
19 Oct 2021	Form 3: Leiderman Elisabeth, Director No securities owned
18 Oct 2021	Form 3: bluebird bio, Inc., 10% owner · 2seventy bio, Inc. Holds 100 shares of Common Stock
01 Oct 2021	Form 3: Glickman Sarah Js, Director No securities owned
01 Oct 2021	Form 3: Tita-Reid Najoh, Director No securities owned
09 Sep 2021	Form 3: Maus Marcela V., Director No securities owned
10 May 2021	Form 3: Klima Thomas J, Chief Commercial Officer, SGD No securities owned
13 Jan 2021	Form 3: Obenshain Andrew, President of SGD Holds 596 shares of Common Stock
11 Jan 2021	Form 3: Ibrahim Ramy, Director No securities owned
09 Sep 2020	Form 3: Burnett Katy, Principal Accounting Officer Holds 1,583 shares of Common Stock
11 Aug 2020	Form 3: Torres Denice, Director Holds 500 shares of Common Stock

Comments